266 related articles for article (PubMed ID: 25132064)
1. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
[TBL] [Abstract][Full Text] [Related]
2. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
[TBL] [Abstract][Full Text] [Related]
3. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
[TBL] [Abstract][Full Text] [Related]
4. Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture.
Rüdiger D; Pelz L; Hein MD; Kupke SY; Reichl U
PLoS Comput Biol; 2021 Sep; 17(9):e1009357. PubMed ID: 34491996
[TBL] [Abstract][Full Text] [Related]
5. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.
Isken B; Genzel Y; Reichl U
Vaccine; 2012 Jul; 30(35):5253-61. PubMed ID: 22698452
[TBL] [Abstract][Full Text] [Related]
6. Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.
Wu M; Zhou E; Sheng R; Fu X; Li J; Jiang C; Su W
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560777
[TBL] [Abstract][Full Text] [Related]
7. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.
Seitz C; Isken B; Heynisch B; Rettkowski M; Frensing T; Reichl U
Appl Microbiol Biotechnol; 2012 Jan; 93(2):601-11. PubMed ID: 21915610
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication.
Kupke SY; Ly LH; Börno ST; Ruff A; Timmermann B; Vingron M; Haas S; Reichl U
Viruses; 2020 Jan; 12(1):. PubMed ID: 31936115
[TBL] [Abstract][Full Text] [Related]
9. Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.
Hein MD; Arora P; Marichal-Gallardo P; Winkler M; Genzel Y; Pöhlmann S; Schughart K; Kupke SY; Reichl U
BMC Biol; 2021 May; 19(1):91. PubMed ID: 33941189
[TBL] [Abstract][Full Text] [Related]
10. Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity.
Bdeir N; Arora P; Gärtner S; Pöhlmann S; Winkler M
Sci Rep; 2021 Oct; 11(1):20477. PubMed ID: 34650149
[TBL] [Abstract][Full Text] [Related]
11. High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.
Seitz C; Frensing T; Höper D; Kochs G; Reichl U
J Gen Virol; 2010 Jul; 91(Pt 7):1754-63. PubMed ID: 20357039
[TBL] [Abstract][Full Text] [Related]
12. Cell culture-based production of defective interfering particles for influenza antiviral therapy.
Wasik MA; Eichwald L; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2018 Feb; 102(3):1167-1177. PubMed ID: 29204901
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Single-Cell Kinetics of Virus Infections in the Presence of Defective Interfering Particles.
Akpinar F; Timm A; Yin J
J Virol; 2016 Feb; 90(3):1599-612. PubMed ID: 26608322
[TBL] [Abstract][Full Text] [Related]
14. Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs.
Laske T; Heldt FS; Hoffmann H; Frensing T; Reichl U
Virus Res; 2016 Feb; 213():90-99. PubMed ID: 26592173
[TBL] [Abstract][Full Text] [Related]
15. Generation of a purely clonal defective interfering influenza virus.
Yamagata Y; Muramoto Y; Miyamoto S; Shindo K; Nakano M; Noda T
Microbiol Immunol; 2019 May; 63(5):164-171. PubMed ID: 30997933
[TBL] [Abstract][Full Text] [Related]
16. Defective interfering viruses and their impact on vaccines and viral vectors.
Frensing T
Biotechnol J; 2015 May; 10(5):681-9. PubMed ID: 25728309
[TBL] [Abstract][Full Text] [Related]
17. Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.
Frensing T; Heldt FS; Pflugmacher A; Behrendt I; Jordan I; Flockerzi D; Genzel Y; Reichl U
PLoS One; 2013; 8(9):e72288. PubMed ID: 24039749
[TBL] [Abstract][Full Text] [Related]
18. Distributed modeling of human influenza A virus-host cell interactions during vaccine production.
Müller T; Dürr R; Isken B; Schulze-Horsel J; Reichl U; Kienle A
Biotechnol Bioeng; 2013 Aug; 110(8):2252-66. PubMed ID: 23475474
[TBL] [Abstract][Full Text] [Related]
19. A system for production of defective interfering particles in the absence of infectious influenza A virus.
Bdeir N; Arora P; Gärtner S; Hoffmann M; Reichl U; Pöhlmann S; Winkler M
PLoS One; 2019; 14(3):e0212757. PubMed ID: 30822349
[TBL] [Abstract][Full Text] [Related]
20. Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes.
Gujuluva CN; Kundu A; Murti KG; Nayak DP
Virology; 1994 Nov; 204(2):491-505. PubMed ID: 7941316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
